The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as ...

"Morphoceuticals is building a platform that has the potential to transform human health,” said Pomerantz. "I am proud to ...

Bristol Myers Squibb (BMY) announced on Friday that its drug, evaluated for myelofibrosis-associated anemia, did not meet its ...

Symptoms of a vitamin C deficiency include weakness, bruising, and dry skin. Learn more about the warning signs and how to get more vitamin C in your diet.

The global cell and tissue preservation market size was US$ 3.1 billion in 2021. The global cell and tissue preservation market are expected to grow to US$ 7.1 billion by 2030 by registering a ...

The global cell culture market is projected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by increasing ...

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

The Conference Forum announces the 15th annual PODD Drug Delivery Conference's 2025 agenda and featured sessions. NEW YORK, July 16, 2025 /PRNewswire/ -- ...